| Primary |
| Drug Use For Unknown Indication |
32.2% |
| Herpes Zoster |
29.7% |
| Genital Herpes |
5.1% |
| Gastric Ulcer |
4.2% |
| Anti-glomerular Basement Membrane Antibody |
3.4% |
| Herpes Simplex |
3.4% |
| Herpes Virus Infection |
3.4% |
| Hiv Infection |
2.5% |
| Hypertension |
2.5% |
| Prostate Cancer |
2.5% |
| Contraception |
1.7% |
| Gastric Disorder |
1.7% |
| Prophylaxis |
1.7% |
| Adenocarcinoma |
0.8% |
| Antiviral Prophylaxis |
0.8% |
| Bone Marrow Transplant |
0.8% |
| Cytomegalovirus Infection |
0.8% |
| Diabetes Mellitus |
0.8% |
| Facial Nerve Disorder |
0.8% |
| Gastritis |
0.8% |
|
| Renal Failure Acute |
19.0% |
| Thrombocytopenia |
7.1% |
| White Blood Cell Count Increased |
7.1% |
| Haemolytic Anaemia |
4.8% |
| Herpes Simplex |
4.8% |
| Product Substitution Issue |
4.8% |
| Psychotic Disorder |
4.8% |
| Rash |
4.8% |
| Speech Disorder |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| Toxic Induced Encephalopathy |
4.8% |
| Toxic Skin Eruption |
4.8% |
| Transaminases Increased |
4.8% |
| Visual Acuity Reduced |
4.8% |
| Anosmia |
2.4% |
| Flatulence |
2.4% |
| Gastritis |
2.4% |
| Hallucination |
2.4% |
| Hepatitis Cholestatic |
2.4% |
| Incoherent |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.6% |
| T-cell Lymphoma |
20.8% |
| Hiv Infection |
12.4% |
| Renal Transplant |
8.5% |
| Multiple Myeloma |
4.2% |
| Ill-defined Disorder |
3.9% |
| Breast Cancer |
3.5% |
| Hypertension |
2.7% |
| Lymphoma |
2.3% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Herpes Zoster |
1.9% |
| B-cell Lymphoma |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Premature Menopause |
1.5% |
| Bone Marrow Transplant |
1.2% |
| Chemotherapy |
1.2% |
| Herpes Virus Infection |
1.2% |
| Hiv Test Positive |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Acute Myeloid Leukaemia |
0.8% |
|
| Tumour Lysis Syndrome |
17.4% |
| Mucosal Inflammation |
6.5% |
| Pyrexia |
6.5% |
| Renal Failure Acute |
6.5% |
| Sepsis |
6.5% |
| Staphylococcal Bacteraemia |
6.5% |
| Vomiting |
6.5% |
| Gun Shot Wound |
4.3% |
| Maculopathy |
4.3% |
| Memory Impairment |
4.3% |
| Pain In Extremity |
4.3% |
| Thrombocytopenia |
4.3% |
| Weight Decreased |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Anaemia |
2.2% |
| Hepatitis Acute |
2.2% |
| Infection |
2.2% |
| Liver Transplant Rejection |
2.2% |
| Nervous System Disorder |
2.2% |
| Neuropathy |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
34.6% |
| Hiv Infection |
11.9% |
| Prophylaxis |
7.7% |
| Product Used For Unknown Indication |
6.2% |
| T-cell Lymphoma |
5.9% |
| Diffuse Large B-cell Lymphoma |
5.6% |
| Chronic Lymphocytic Leukaemia |
4.4% |
| Multiple Myeloma |
4.3% |
| Hypertension |
2.8% |
| Immunosuppression |
2.4% |
| Antifungal Prophylaxis |
2.0% |
| Renal Transplant |
1.8% |
| Antiviral Prophylaxis |
1.6% |
| Anaemia |
1.5% |
| Liver Transplant |
1.4% |
| Pain |
1.4% |
| Mantle Cell Lymphoma |
1.3% |
| Infection Prophylaxis |
1.3% |
| B-cell Lymphoma |
1.1% |
| Acute Lymphocytic Leukaemia |
1.0% |
|
| Vomiting |
11.8% |
| Thrombocytopenia |
9.0% |
| Venous Thrombosis Limb |
7.3% |
| Pyrexia |
6.9% |
| Pulmonary Embolism |
6.1% |
| Febrile Neutropenia |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Toxic Epidermal Necrolysis |
5.3% |
| Cytomegalovirus Infection |
4.1% |
| Sepsis |
4.1% |
| Weight Decreased |
4.1% |
| Pancytopenia |
3.7% |
| Polyarthritis |
3.7% |
| Renal Failure Acute |
3.7% |
| Pneumonia |
3.3% |
| Renal Failure |
3.3% |
| Transaminases Increased |
3.3% |
| Wound Evisceration |
3.3% |
| Death |
2.9% |
| Mucosal Inflammation |
2.9% |
|
